Respirogen to raise $3 million in equity offering
BOULDER — Respirogen Inc., a Boulder-based bioscience company, is raising $3 million in capital.
The company has raised $500,000 in an equity offering so far, according to a Form D filed with the U.S. Securities and Exchange Commission on Sept. 20. The date of first sale was Sept. 18.
The company is raising the funds for research and development activity, CEO Robert Scribner told BizWest.
SPONSORED CONTENT
Scribner added that the company is developing a novel therapy for oxygen delivery in lung-injured patients.
BOULDER — Respirogen Inc., a Boulder-based bioscience company, is raising $3 million in capital.
The company has raised $500,000 in an equity offering so far, according to a Form D filed with the U.S. Securities and Exchange Commission on Sept. 20. The date of first sale was Sept. 18.
The company is raising the funds for research and development activity, CEO Robert Scribner told BizWest.
Scribner added that the company is developing a novel therapy for oxygen delivery in lung-injured patients.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Medical-device firm Boulder iQ has nearly doubled its Boulder footprint with the purchase of a…
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
-
Tilled Inc., a Boulder payment-facilitation technology company, recently completed a $12.5 million investment round, bringing…
-
OnKure Inc., a Boulder precision oncology company, and California-based Reneo Pharmaceuticals Inc. have completed a…
